Annual Retained Earnings
-$13.52 M
-$7.38 M-120.23%
December 31, 2023
Summary
- As of February 7, 2025, CHRO annual retained earnings is -$13.52 million, with the most recent change of -$7.38 million (-120.23%) on December 31, 2023.
- During the last 3 years, CHRO annual retained earnings has fallen by -$9.94 million (-277.87%).
- CHRO annual retained earnings is now -277.87% below its all-time high of -$3.58 million, reached on December 1, 2020.
Performance
CHRO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$19.55 M
-$1.69 M-9.49%
September 30, 2024
Summary
- As of February 7, 2025, CHRO quarterly retained earnings is -$19.55 million, with the most recent change of -$1.69 million (-9.49%) on September 30, 2024.
- Over the past year, CHRO quarterly retained earnings has dropped by -$6.03 million (-44.59%).
- CHRO quarterly retained earnings is now -431.16% below its all-time high of -$3.68 million, reached on December 1, 2021.
Performance
CHRO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CHRO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -120.2% | -44.6% |
| 3 y3 years | -277.9% | -262.0% |
| 5 y5 years | -277.9% | -262.0% |
CHRO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -267.4% | at low | -431.2% | at low |
| 5 y | 5-year | -277.9% | at low | -431.2% | at low |
| alltime | all time | -277.9% | at low | -431.2% | at low |
Chromocell Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$19.55 M(+9.5%) |
| Jun 2024 | - | -$17.85 M(+11.0%) |
| Mar 2024 | - | -$16.08 M(+19.0%) |
| Dec 2023 | -$13.52 M | -$13.52 M(+42.6%) |
| Sep 2023 | - | -$9.48 M(+17.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$8.06 M(+13.4%) |
| Mar 2023 | - | -$7.11 M(+15.7%) |
| Dec 2022 | -$6.14 M(+66.8%) | -$6.14 M(+13.7%) |
| Sep 2022 | - | -$5.40 M(+46.7%) |
| Dec 2021 | -$3.68 M(+2.9%) | -$3.68 M |
| Dec 2020 | -$3.58 M | - |
FAQ
- What is Chromocell Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Chromocell Therapeutics?
- What is Chromocell Therapeutics annual retained earnings year-on-year change?
- What is Chromocell Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly retained earnings year-on-year change?
What is Chromocell Therapeutics annual retained earnings?
The current annual retained earnings of CHRO is -$13.52 M
What is the all time high annual retained earnings for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual retained earnings is -$3.58 M
What is Chromocell Therapeutics annual retained earnings year-on-year change?
Over the past year, CHRO annual retained earnings has changed by -$7.38 M (-120.23%)
What is Chromocell Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CHRO is -$19.55 M
What is the all time high quarterly retained earnings for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly retained earnings is -$3.68 M
What is Chromocell Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CHRO quarterly retained earnings has changed by -$6.03 M (-44.59%)